Silent Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis in the Lower Lim…

[Read more →]

D-Dimer Threshold Increase with Pretest Probability Unlikely for Pulmonary Embolism to De…

[Read more →]

Is atrial fibrillation associated with pulmonary embolism?
J Thromb Haemost. 2011…

[Read more →]

A Simple Reminder System Improves Venous Thromboembolism Prophylaxis Rates and Reduces Th…

[Read more →]

Baseline Imaging After Therapy for Unprovoked Venous Thromboembolism: A Randomised Controlled Comparison of Baseline Imaging for Diagnosis of Suspected Recurrence.
J Thromb Haemost. 2011 Oct 11;
Authors: Hamadah A, Alwasaidi T…

[Read more →]

Economic burden and cost determinants of deep vein thrombosis during two years following diagnosis: a prospective evaluation.
J Thromb Haemost. 2011 Sep 22;
Authors: Guanella R, Ducruet T, Johri M, Miron MJ, Roussin A, Desmara…

[Read more →]

Treatment of Upper-Extremity Deep-Vein Thrombosis.
J Thromb Haemost. 2011 Aug 12;
Authors: Rathbun SW, Stoner JA, Whitsett TL
Background: Upper extremity deep-vein thrombosis (DVT) can result in fatal pulmonary embolis…

[Read more →]

No Accumulation of the Peak Anti-Xa Activity of Tinzaparin in Elderly Patients with Moderate-to-Severe Renal Impairment: the IRIS Substudy.
J Thromb Haemost. 2011 Aug 5;
Authors: Siguret V, Gouin-Thibault I, Pautas E, Leizorov…

[Read more →]

Comparison of two Prognostic Models for Acute Pulmonary Embolism: clinical vs right Ventricular Dysfunction Guided Approach.
J Thromb Haemost. 2011 Aug 5;
Authors: Vanni S, Nazerian P, Pepe G, Baioni M, Michele R, Grifoni G, V…

[Read more →]

Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa.
J Thromb Haemost. 2011 Jul;9 Suppl 1:12-9
Authors: Bauer KA
Summary.? While parenteral anticoagulants such as unfractionated…

[Read more →]

Management of acquired haemophilia A.
J Thromb Haemost. 2011 Jul;9 Suppl 1:226-35
Authors: Collins PW
Summary.? Acquired haemophilia A is an auto-immune disease caused by an inhibitory antibody to factor VIII. The pa…

[Read more →]

How to prevent, treat, and overcome current clinical challenges of VTE.
J Thromb Haemost. 2011 Jul;9 Suppl 1:265-74
Authors: VAN Es J, Eerenberg ES, Kamphuisen PW, Büller HR
Summary.? Venous thromboembolism (VTE) is…

[Read more →]

Management of venous thromboembolism in patients with cancer.
J Thromb Haemost. 2011 Jul;9 Suppl 1:316-24
Authors: Agnelli G, Verso M
Summary.? Patients with cancer are at increased risk of venous thromboembolism (VT…

[Read more →]

Stroke in atrial fibrillation: epidemiology and thromboprophylaxis.
J Thromb Haemost. 2011 Jul;9 Suppl 1:344-51
Authors: Lip GY
Summary.? Atrial fibrillation (AF) is the commonest sustained cardiac rhythm disorder, w…

[Read more →]

Racial Differences in Venous Thromboembolism.
J Thromb Haemost. 2011 Jul 28;
Authors: Zakai NA, McClure LA
The incidence of venous thrombosis (VTE) varies by race, with African-Americans having over five-fold greater i…

[Read more →]